Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online February 11, 2008
Diabetes Care 31:882-883, 2008
DOI: 10.2337/dc07-1912
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-1912v1
31/5/882    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Pérez-Jáuregui, J.
Right arrow Articles by Aguilar-Salinas, C. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pérez-Jáuregui, J.
Right arrow Articles by Aguilar-Salinas, C. A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Clinical Care/Education/Nutrition/Psychosocial Research
Original Research

Inclusion of Educational Messages in Laboratory Reports Aids to Complete the Diagnostic Workup of Hyperglycemia

José Pérez-Jáuregui, MD1, Ana María González-Cardel, BS2, Gabriela Olay-Fuentes, BS3, Alfredo Reza-Albarrán, MD4, Roopa Mehta, MD4 and Carlos A. Aguilar-Salinas, MD4

1 Dirección Corporativa de Medicina de Laboratorio, Laboratorio Médico del Chopo, México City, México
2 Especialización en Bioquímica Clínica, Facultad de Química de la Universidad Nacional Autónoma de México, México City, México
3 Departamento de Inmuno-Química, Carpermor, Laboratorio de Referencia Internacional, México City, México
4 Departamento de Endocrinología y Metabolismo, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, México

Corresponding author: José Pérez-Jáuregui, MD, Dirección Corporativa de Medicina de Laboratorio, Laboratorio Médico del Chopo, Alfonso Herrera 75, Col San Rafael, México City, México. E-mail: jose.perezjauregui{at}proa.com.mx

OBJECTIVE—To evaluate whether educational messages regarding oral glucose tolerance test (OGTT) indications in laboratory reports increase the number of OGTTs appropriately requested.

RESEARCH DESIGN AND METHODS—The following message was printed on the lab reports of individuals with a fasting plasma glucose (FPG) concentration between 5.5 and 6.9 mmol/l: "A FPG between 5.5 and 6.9 mmol/l is considered abnormal by the American Diabetes Association (impaired fasting glucose). An OGTT is recommended if the patient does not have a diagnosis of diabetes and suffers from conditions associated with an increased risk for having type 2 diabetes (i.e., overweight, high blood pressure, abnormal plasma lipids or family history of diabetes)." The number of educational messages printed was 81,099.

RESULTS—The intervention resulted in a significant increase in the number of OGTTs requested, from 78 ± 19 to 268 ± 48 tests per month. It also resulted in a greater proportion of case subjects that had an abnormal OGTT result.

CONCLUSIONS—Educational messages in laboratory reports aid in the diagnostic workup of hyperglycemia.

Abbreviations: FPG, fasting plasma glucose • OGTT, oral glucose tolerance test


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.